North America Compounding Pharmacies Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Compounding Pharmacies Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Compounding Pharmacies Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Compounding Pharmacies Market Regional Analysis

6.2 North America Compounding Pharmacies Market Revenue 2019-2028 (US$ Million)

6.3 North America Compounding Pharmacies Market Forecast Analysis

7. North America Compounding Pharmacies Market Analysis – by Product

7.1 Oral Medications

7.1.1 Overview
7.1.2 Oral Medications: North America Compounding Pharmacies Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Topical Medications

7.2.1 Overview
7.2.2 Topical Medications: North America Compounding Pharmacies Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Suppositories

7.3.1 Overview
7.3.2 Suppositories: North America Compounding Pharmacies Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Compounding Pharmacies Market Analysis – by Therapeutic Area

8.1 Pain Medications

8.1.1 Overview
8.1.2 Pain Medications: North America Compounding Pharmacies Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Hormone Replacement Therapies

8.2.1 Overview
8.2.2 Hormone Replacement Therapies: North America Compounding Pharmacies Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Dermatological Applications

8.3.1 Overview
8.3.2 Dermatological Applications: North America Compounding Pharmacies Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Compounding Pharmacies Market – North America Analysis

9.1 Overview

9.2 North America

9.2.1 North America Compounding Pharmacies Market Breakdown, by Key Country, 2022 and 2028 (%)
9.2.1.1 North America Compounding Pharmacies Market – Revenue and Forecast Analysis – by Country
9.2.1.1 US: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.1.1 US: North America Compounding Pharmacies Market Breakdown, by Product
9.2.1.1.2 US: North America Compounding Pharmacies Market Breakdown, by Therapeutic Area

9.2.1.2 Canada: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.2.1 Canada: North America Compounding Pharmacies Market Breakdown, by Product
9.2.1.2.2 Canada: North America Compounding Pharmacies Market Breakdown, by Therapeutic Area

9.2.1.3 Mexico : North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.3.1 Mexico : North America Compounding Pharmacies Market Breakdown, by Product
9.2.1.3.2 Mexico : North America Compounding Pharmacies Market Breakdown, by Therapeutic Area

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Avella specialty pharmacy

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 B.Braun Melsungen AG

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Fagron, Inc

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Fresenius Kabi AG

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 PharMEDium Healthcare Holdings, Inc

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Triangle Compounding Pharmacy

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 US Compounding Inc

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Vertisis Custom Pharmacy

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

North America Compounding Pharmacies Market

Analysis By Product (Oral Medications, Topical Medications, Suppositories, and Others) and Therapeutic Area (Pain Medications, Hormone Replacement Therapies, Dermatological Applications, and Others)